SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001047469-18-003170
Filing Date
2018-04-25
Accepted
2018-04-25 16:19:08
Documents
3
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A a2235480z10-ka.htm 10-K/A 318574
2 EX-31.1 a2235480zex-31_1.htm EX-31.1 4152
3 EX-31.2 a2235480zex-31_2.htm EX-31.2 4123
  Complete submission text file 0001047469-18-003170.txt   328027
Mailing Address 375 PHEASANT RUN NEWTOWN PA 18940
Business Address 375 PHEASANT RUN NEWTOWN PA 18940 267-759-3681
Onconova Therapeutics, Inc. (Filer) CIK: 0001130598 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-36020 | Film No.: 18774578
SIC: 2834 Pharmaceutical Preparations